How analysts predict Jaguar Health Inc (JAGX) will perform this quarter?

Jaguar Health Inc (JAGX)’s stock is trading at $0.08 at the moment marking a fall of -0.24% from the last session close. As of this writing, shares are priced at -93.13% less than their 52-week high of $1.22, and 63.67% over their 52-week low of $0.05. Based on the past 30-day period, the stock price is -11.81% below the high and +36.59% above the low.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, JAGX’s SMA-200 is $0.2827.

Further, it is important to consider JAGX stock ratios, particularly its price-to-sales ratio over the past twelve months, which stands at 1.79.JAGX’s price to book ratio for the most recent quarter was 1.24, resulting in an 2.70 price to cash per share for the period.

How does Jaguar Health Inc (JAGX) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.

Jaguar Health Inc (JAGX): Earnings History

If we examine Jaguar Health Inc’s recent earnings history, in the last quarter ended on 9/29/2023, it posted adjusted earnings per share of -$0.55, slashing the consensus of -$1.23. In other words, it beat the consensus by $0.68, resulting in a 55.30% surprise. In the 3 months period before the previous quarter which was closed on 9/29/2023, the stock recorded adjusted earnings per share of -$0.55 in contrast with the Outlook of -$1.23. That was a difference of $0.68 and a surprise of 55.30%.

Jaguar Health Inc (NASDAQ: JAGX) Ownership Details

I will give a breakdown of the key shareholders in Jaguar Health Inc (JAGX). Recent figures show that the company’s insiders hold 2.11% of shares. A total of 22 institutional investors hold shares in the company, making 0.53% of its stock and 0.54% of its float.

Jun 29, 2023, it was reported that the Company’s largest institutional holder is Geode Capital Management, LLC holding total of 92333.0 shares that make 0.48% of the company’s total number of shares and are currently priced at 47643.0.

The securities firm Vanguard Group Inc holds 79565.0 shares of JAGX, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.42%, and the holding percentage of shares is valued at 41055.0.

An overview of Jaguar Health Inc’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Jaguar Health Inc (JAGX) traded 44,806,879 shares per day, with a moving average of $0.0752 and price change of +0.0066. With the moving average of $0.0818 and a price change of -0.0269, about 47,468,613 shares changed hands on average over the past 50 days. Finally, JAGX’s 100-day average volume is 27,322,988 shares, alongside a moving average of $0.1500 and a price change of -0.2039.

Related Posts